drugset / Trial / NCT03932019
Study of Jitongning Tablet to Treat Spondyloarthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is to investigate the efficacy and safety of Jitongning Tablet in improving joint function and pain symptoms in active axial spondyloarthritis (SpA) patients and to explore the optimal dosage.
Timeline
- Start
- 2019-06-11
- Primary completion
- 2021-06-20
- Completion
- 2021-08-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Jitongning Tablet | Unknown | 2 unknown | Oral |
| Subject | Jitongning Tablet | Unknown | 3 unknown | Oral |